CoChat

Deep Learning for Novel Antimicrobial Peptide Design

Open access
Wang, Christina, Garlick, Sam, Zloh, Mire · 2021 · Biomolecules
Cited by 105

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Antimicrobial resistance is an increasing issue in healthcare as the overuse of antibacterial agents rises during the COVID-19 pandemic. The need for new antibiotics is high, while the arsenal of available agents is decreasing, especially for the treatment of infections by Gram-negative bacteria like Escherichia coli. Antimicrobial peptides (AMPs) are offering a promising route for novel antibiotic development and deep learning techniques can be utilised for successful AMP design. In this study, a long short-term memory (LSTM) generative model and a bidirectional LSTM classification model were constructed to design short novel AMP sequences with potential antibacterial activity against E. coli. Two versions of the generative model and six versions of the classification model were trained and optimised using Bayesian hyperparameter optimisation. These models were used to generate sets of short novel sequences that were classified as antimicrobial or non-antimicrobial. The validation accuracies of the classification models were 81.6–88.9% and the novel AMPs were classified as antimicrobial with accuracies of 70.6–91.7%. Predicted three-dimensional conformations of selected short AMPs exhibited the alpha-helical structure with amphipathic surfaces. This demonstrates that LSTMs are effective tools for generating novel AMPs against targeted bacteria and could be utilised in the search for new antibiotics leads.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom11030471

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 76

  1. Signore, A., and Glaudemans, A.W.J.M. (2019). Infections: The Emergency of the New Millennium. Nuclear Medicine in Infectious Diseases, Springer.
  2. O’Neil, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance, AMR-Review.
  3. Sohrabi, 2020, World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19), Int. J. Surg., 76, 71, 10.1016/j.ijsu.2020.02.034 · DOI · Paper page
  4. Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
  5. Rawson, 2020, COVID-19 and the potential long-term impact on antimicrobial resistance, J. Antimicrob. Chemother., 75, 1681, 10.1093/jac/dkaa194 · DOI · Paper page
  6. Moravej, 2018, Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria, Microb. Drug Resist., 24, 747, 10.1089/mdr.2017.0392 · DOI · Paper page
  7. Pushpanathan, 2013, Antimicrobial Peptides: Versatile Biological Properties, Int. J. Pept., 2013, 1, 10.1155/2013/675391 · DOI · Paper page
  8. Chen, 2005, Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index, J. Biol. Chem., 280, 12316, 10.1074/jbc.M413406200 · DOI · Paper page
  9. Passarini, I., Rossiter, S., Malkinson, J., and Zloh, M. (2018). In Silico Structural Evaluation of Short Cationic Antimicrobial Peptides. Pharmaceutics, 10. · DOI
  10. Pfalzgraff, 2018, Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds, Front. Pharmacol., 9, 281, 10.3389/fphar.2018.00281 · DOI · Paper page
  11. Koprivnjak, 2011, Bacterial resistance mechanisms against host defense peptides, Cell. Mol. Life Sci., 68, 2243, 10.1007/s00018-011-0716-4 · DOI
  12. Marr, 2006, Antibacterial peptides for therapeutic use: Obstacles and realistic outlook, Curr. Opin. Pharmacol., 6, 468, 10.1016/j.coph.2006.04.006 · DOI · Paper page
  13. Lee, 2015, A Large-Scale Structural Classification of Antimicrobial Peptides, BioMed Res. Int., 2015, 1
  14. Wang, 2016, APD3: The antimicrobial peptide database as a tool for research and education, Nucleic Acids Res., 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  15. Pirtskhalava, 2016, DBAASP v.2: An enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides, Nucleic Acids Res., 44, D1104, 10.1093/nar/gkv1174 · DOI · Paper page
  16. Kang, 2019, DRAMP 2.0, an updated data repository of antimicrobial peptides, Sci. Data, 6, 1, 10.1038/s41597-019-0154-y · DOI · Paper page
  17. Witten, J., and Witten, Z. (2019). Deep learning regression model for antimicrobial peptide design. bioRxiv, 692681. · DOI · Paper page
  18. Zhao, X., Wu, H., Lu, H., Li, G., and Huang, Q. (2013). LAMP: A Database Linking Antimicrobial Peptides. PLoS ONE, 8. · DOI · Paper page
  19. Piotto, 2012, YADAMP: Yet another database of antimicrobial peptides, Int. J. Antimicrob. Agents, 39, 346, 10.1016/j.ijantimicag.2011.12.003 · DOI · Paper page
  20. Meher, 2017, Predicting antimicrobial peptides with improved accuracy by incorporating the compositional, physico-chemical and structural features into Chou’s general PseAAC, Sci. Rep., 7, srep42362, 10.1038/srep42362 · DOI · Paper page
  21. Lata, S., Sharma, B., and Raghava, G. (2007). Analysis and prediction of antibacterial peptides. BMC Bioinform., 8. · DOI · Paper page
  22. Lata, 2010, AntiBP2: Improved version of antibacterial peptide prediction, BMC Bioinform., 11, S19, 10.1186/1471-2105-11-S1-S19 · DOI · Paper page
  23. Torrent, M., Nogués, V.M., and Boix, E. (2009). A theoretical approach to spot active regions in antimicrobial proteins. BMC Bioinform., 10. · DOI
  24. Torrent, M., Andreu, D., Nogués, V.M., and Boix, E. (2011). Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model. PLoS ONE, 6. · DOI · Paper page
  25. Torrent, 2012, AMPA: An automated web server for prediction of protein antimicrobial regions, Bioinformatics, 28, 130, 10.1093/bioinformatics/btr604 · DOI · Paper page
  26. Wang, P., Hu, L., Liu, G., Jiang, N., Chen, X., Xu, J., Zheng, W., Li, L., Tan, M., and Chen, Z. (2011). Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods. PLoS ONE, 6. · DOI · Paper page
  27. Khosravian, 2013, Predicting Antibacterial Peptides by the Concept of Chou’s Pseudo-amino Acid Composition and Machine Learning Methods, Protein Pept. Lett., 20, 180, 10.2174/092986613804725307 · doi:10.2174/092986613804725307
  28. Xiao, 2013, iAMP-2L: A two-level multi-label classifier for identifying antimicrobial peptides and their functional types, Anal. Biochem., 436, 168, 10.1016/j.ab.2013.01.019 · DOI · Paper page
  29. Bhadra, 2018, AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest, Sci. Rep., 8, 1, 10.1038/s41598-018-19752-w · DOI · Paper page
  30. Joseph, 2012, ClassAMP: A Prediction Tool for Classification of Antimicrobial Peptides, IEEE/ACM Trans. Comput. Biol. Bioinform., 9, 1535, 10.1109/TCBB.2012.89 · DOI
  31. Fjell, 2009, Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning, J. Med. Chem., 52, 2006, 10.1021/jm8015365 · DOI · Paper page
  32. Porto, W.F., Pires, Á.S., and Franco, O.L. (2012). CS-AMPPred: An Updated SVM Model for Antimicrobial Activity Prediction in Cysteine-Stabilized Peptides. PLoS ONE, 7. · DOI
  33. Veltri, 2018, Deep learning improves antimicrobial peptide recognition, Bioinformatics, 34, 2740, 10.1093/bioinformatics/bty179 · DOI · Paper page
  34. Su, 2019, Antimicrobial peptide identification using multi-scale convolutional network, BMC Bioinform., 20, 1, 10.1186/s12859-019-3327-y · DOI
  35. Fang, 2019, Prediction of Antifungal Peptides by Deep Learning with Character Embedding, IPSJ Trans. Bioinform., 12, 21, 10.2197/ipsjtbio.12.21 · DOI
  36. Nagarajan, 2018, Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria, J. Biol. Chem., 293, 3492, 10.1074/jbc.M117.805499 · DOI · Paper page
  37. Zhou, P., Qi, Z., Zheng, S., Xu, J., Bao, H., and Xu, B. (2016). Text Classification Improved by Integrating Bidirectional LSTM with Two-dimensional Max Pooling. arXiv.
  38. Liu, 2019, Bidirectional LSTM with attention mechanism and convolutional layer for text classification, Neurocomputing, 337, 325, 10.1016/j.neucom.2019.01.078 · DOI · Paper page
  39. Rice, 2008, Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE, J. Infect. Dis., 197, 1079, 10.1086/533452 · DOI · Paper page
  40. World Health Organization (2017). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics, WHO Press.
  41. Weeks, 2018, Engineering peptide ligase specificity by proteomic identification of ligation sites, Nat. Chem. Biol., 14, 50, 10.1038/nchembio.2521 · DOI
  42. Ghojogh, B., and Crowley, M. (2019). The Theory Behind Overfitting, Cross Validation, Regularization, Bagging, and Boosting: Tutorial. arXiv.
  43. Dwarampudi, M., and Reddy, N. (2019). Effects of padding on LSTMs and CNNs. arXiv.
  44. Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., and Raghava, G.P.S. (2013). Open Source Drug Discovery Consortium in Silico Approach for Predicting Toxicity of Peptides and Proteins. PLoS ONE, 8. · DOI · Paper page
  45. Lamiable, 2016, PEP-FOLD3: Fasterde novostructure prediction for linear peptides in solution and in complex, Nucleic Acids Res., 44, W449, 10.1093/nar/gkw329 · DOI · Paper page
  46. Pettersen, 2004, UCSF Chimera—A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  47. Abadi, M., Barham, P., Chen, J., Chen, Z., Davis, A., Dean, J., Devin, M., Ghemawat, S., Irving, G., and Isard, M. (2016, January 2–4). Tensorflow: A system for large-scale machine learning. Proceedings of the 12th USENIX Symposium on Operating Systems Design and Implementation, Savannah, GA, USA.
  48. Hunter, 2007, Matplotlib: A 2D Graphics Environment, Comput. Sci. Eng., 9, 90, 10.1109/MCSE.2007.55 · DOI · Paper page
  49. Pedregosa, 2011, Scikit-learn: Machine Learning in Python, JMLR, 12, 2825
  50. McKinney, W. (July, January 28). Data Structures for Statistical Computing in Python. Proceedings of the 9th Python in Science Conference, Austin, TX, USA.
  51. Passarini, I., De Resende, P.E., Soares, S., Tahmasi, T., Stapleton, P., Malkinson, J., Zloh, M., and Rossiter, S. (2020). Synthesis and in Silico Modelling of the Potential Dual Mechanistic Activity of Small Cationic Peptides Potentiating the Antibiotic Novobiocin against Susceptible and Multi-Drug Resistant Escherichia coli. Int. J. Mol. Sci., 21. · doi:10.3390/ijms21239134
  52. Pitout, 2012, Extraintestinal pathogenicEscherichia coli: An update on antimicrobial resistance, laboratory diagnosis and treatment, Expert Rev. Anti-Infect. Ther., 10, 1165, 10.1586/eri.12.110 · DOI · Paper page
  53. Sainz, 2019, Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection, Eur. J. Clin. Microbiol. Infect. Dis., 38, 2097, 10.1007/s10096-019-03643-7 · doi:10.1007/s10096-019-03643-7
  54. Kidsley, 2018, Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey, Front. Microbiol., 9, 1207, 10.3389/fmicb.2018.01207 · DOI
  55. Sun, 2009, Classification of Imbalanced Data: A Review, Int. J. Pattern Recognit. Artif. Intell., 23, 687, 10.1142/S0218001409007326 · DOI · Paper page
  56. Kotsiantis, 2005, Handling imbalanced datasets: A review, GESTS Int. Tran. Comput. Sci. Eng., 30, 25
  57. Wu, 2019, Hyperparameter Optimization for Machine Learning Models Based on Bayesian Optimizationb, JEST, 17, 26
  58. Bergstra, J., Yamins, D., and Cox, D.D. (2013, January 17–19). Making a Science of Model Search: Hyperparameter Optimization in Hundreds of Dimensions for Vision Architectures. Proceedings of the 30th International Conference on International Conference on Machine Learning (ICML’13), Atlanta, GA, USA.
  59. Hutter, F., Kotthoff, L., and Vanschoren, J. (2019). Hyperparameter Optimization. Automated Machine Learning, Springer. · DOI · Paper page
  60. Tucs, 2020, Generating Ampicillin-Level Antimicrobial Peptides with Activity-Aware Generative Adversarial Networks, ACS Omega, 5, 22847, 10.1021/acsomega.0c02088 · DOI · Paper page
  61. Svenson, 2008, Antimicrobial Peptides with Stability toward Tryptic Degradation, Biochemistry, 47, 3777, 10.1021/bi7019904 · DOI
  62. Whitcomb, 2007, Human Pancreatic Digestive Enzymes, Dig. Dis. Sci., 52, 1, 10.1007/s10620-006-9589-z · DOI · Paper page
  63. McGregor, 2008, Discovering and improving novel peptide therapeutics, Curr. Opin. Pharmacol., 8, 616, 10.1016/j.coph.2008.06.002 · DOI · Paper page
  64. Castillo, 2014, Analysis of Structure and Hemolytic Activity Relationships of Antimicrobial Peptides (AMPs), Advances in Computational Biology, Volume 232, 253, 10.1007/978-3-319-01568-2_36 · doi:10.1007/978-3-319-01568-2_36
  65. Park, 2010, In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains, Int. J. Antimicrob. Agents, 35, 208, 10.1016/j.ijantimicag.2009.10.010 · DOI
  66. Wang, 2010, Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich α-helical model antimicrobial peptide and its diastereomeric peptides, Peptides, 31, 1251, 10.1016/j.peptides.2010.03.032 · DOI
  67. Park, 2015, Advances in the synthesis and application of nanoparticles for drug delivery, Wiley Interdiscip. Rev. Nanomed. Nanobiotech., 7, 494, 10.1002/wnan.1325 · DOI · Paper page
  68. Chongsiriwatana, 2008, Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides, Proc. Natl. Acad. Sci. USA, 105, 2794, 10.1073/pnas.0708254105 · DOI · Paper page
  69. Vagner, 2008, Peptidomimetics, a synthetic tool of drug discovery, Curr. Opin. Chem. Biol., 12, 292, 10.1016/j.cbpa.2008.03.009 · DOI · Paper page
  70. Kuppusamy, R., Willcox, M., Black, D.S., and Kumar, N. (2019). Short Cationic Peptidomimetic Antimicrobials. Antibiotics, 8. · DOI
  71. Barriere, 1992, Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy, Pharmacotherapy, 12, 397, 10.1002/j.1875-9114.1992.tb04478.x · DOI
  72. Wu, 1999, Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa, J. Antimicrob. Chemother., 44, 389, 10.1093/jac/44.3.389 · DOI
  73. Steenbergen, 2009, Effects of daptomycin in combination with other antimicrobial agents: A review of in vitro and animal model studies, J. Antimicrob. Chemother., 64, 1130, 10.1093/jac/dkp346 · DOI
  74. Park, 2004, Antibacterial synergism of novel antibiotic peptides with chloramphenicol, Biochem. Biophys. Res. Commun., 321, 109, 10.1016/j.bbrc.2004.06.113 · DOI
  75. Park, 2006, Synergism of Leu–Lys rich antimicrobial peptides and chloramphenicol against bacterial cells, Biochim. Biophys. Acta, 1764, 24, 10.1016/j.bbapap.2005.10.019 · DOI
  76. Giacometti, 2004, In vitro activity and killing effect of the synthetic hybrid cecropin A–melittin peptide CA(1–7)M(2–9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics, Diagn. Microbiol. Infect. Dis., 49, 197, 10.1016/j.diagmicrobio.2004.02.008 · DOI

Cited by

See all 105

Metadata

Authors
Wang, C., Garlick, S., & Zloh, M.
Venue
Biomolecules
Publisher
MDPI AG
Published
2021-03-22
Volume
11
Issue
3
Pages
471
ISSN
2218-273X (ISSN-L)
OpenAlex
W3136366652
Cited by
105
References
10
FWCI
8.39
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep Learning for Novel Antimicrobial Peptide Design. https://app.cochat.ai/papers/10.3390/biom11030471
The paper
Wang, C., Garlick, S., & Zloh, M. (2021). Deep Learning for Novel Antimicrobial Peptide Design. Biomolecules. https://doi.org/10.3390/biom11030471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.